This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lis, M. Articles by Kuramitsu, H. K. Search for Related Content PubMed PubMed Citation Articles by Lis, M. Articles by Kuramitsu, H. K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 05 1997, 999-1003, Vol 41, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Galactose oxidase-glucan binding domain fusion proteins as targeting inhibitors of dental plaque bacteria

M Lis and HK Kuramitsu
Department of Oral Biology, State University of New York at Buffalo, 14214, USA.

In order to inhibit the growth of bacteria present in the human oral cavity, a novel system which targets antimicrobial agents to dental plaque has been developed. This system involves a hybrid protein consisting of a peptide expressing the bactericidal properties of galactose oxidase (GAO) fused to the glucan binding domain (GBD) of the Streptococcus mutans glucosyltransferase-S enzyme. A gene encoding GAO from the fungus Fusarium sp. has been inserted into an Escherichia coli expression vector and fused to sequences encoding the GBD, which binds to the glucans synthesized by oral streptococci. Bacterial extracts expressing the hybrid protein were tested for their ability to target the GAO activity to an in vitro plaque model consisting of streptococcal cells bound to microtiter plate wells. The binding of the hybrid protein to the streptococcal cells through its GBD and the dependence of binding on the production of glucans by bacteria were demonstrated. Furthermore, killing of three different species of oral streptococci by bound hybrid protein in conjunction with the galactose- lactoperoxidase-iodide cytotoxic system has been demonstrated. These results suggest a novel strategy for controlling dental plaque formation as well as dental caries in humans.

This article has been cited by other articles:

• Shimotsuura, I., Kigawa, H., Ohdera, M., Kuramitsu, H. K., Nakashima, S. (2008). Biochemical and Molecular Characterization of a Novel Type of Mutanase from Paenibacillus sp. Strain RM1: Identification of Its Mutan-Binding Domain, Essential for Degradation of Streptococcus mutans Biofilms. Appl. Environ. Microbiol. 74: 2759-2765 [Abstract] [Full Text]  
• Szynol, A., de Soet, J. J., Sieben-van Tuyl, E., Bos, J. W., Frenken, L. G. (2004). Bactericidal Effects of a Fusion Protein of Llama Heavy-Chain Antibodies Coupled to Glucose Oxidase on Oral Bacteria. Antimicrob. Agents Chemother. 48: 3390-3395 [Abstract] [Full Text]  
• Sun, L., Petrounia, I. P., Yagasaki, M., Bandara, G., Arnold, F. H. (2001). Expression and stabilization of galactose oxidase in Escherichia coli by directed evolution. Protein Eng Des Sel 14: 699-704 [Abstract] [Full Text]  
• Kaseda, K., Yokota, H., Ishii, Y., Yanagida, T., Inoue, T., Fukui, K., Kodama, T. (2000). Single-Molecule Imaging of Interaction between Dextran and Glucosyltransferase from Streptococcus sobrinus. J. Bacteriol. 182: 1162-1166 [Abstract] [Full Text]  
• Burne, R.A. (1998). Oral Streptococci... Products of Their Environment. JDR 77: 445-452 [Abstract]